Arcus Biosciences, Inc.

Healthcare

NYSE:RCUS · New York Stock Exchange

Market Cap $2.45B Beta 0.84 P/E (TTM) -8.2

$24.31 -0.39%

-$0.09 today

52W Low $7.91High $28.72

Vol 1.12M · Avg 1.17M

EPS (TTM) -$2.94Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+181.69%

Period High

$26.62

Period Low

$7.95

Latest

$24.31

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

ImmunityBio, Inc.

NASDAQ:IBRX

$7.40B

Liquidia Corporation

NASDAQ:LQDA

$6.03B

Cogent Biosciences, Inc.

NASDAQ:COGT

$5.87B

Denali Therapeutics Inc.

NASDAQ:DNLI

$3.71B

Beam Therapeutics Inc.

NASDAQ:BEAM

$3.39B

89bio, Inc.

ETNB

$2.20B

Ocular Therapeutix, Inc.

NASDAQ:OCUL

$2.11B

Agios Pharmaceuticals, Inc.

NASDAQ:AGIO

$2.01B

Galapagos N.V.

GLPG

$1.84B

Viridian Therapeutics, Inc.

NASDAQ:VRDN

$1.50B

What is the latest RCUS filing?

The latest filing shown is 4 dated Jun 12, 2026.

How many recent filings does RCUS have?

Intrinsic Alpha currently shows 20 recent filings for RCUS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.